Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.
复制标题
DOI:
10.1002/hep.23535
复制
发表时间:
2010-06
期刊:
影响因子:
13.5
通讯作者:
Diehl, Anna Mae
中科院分区:
文献类型:
--
作者:
Abdelmalek, Manal F.;Suzuki, Ayako;Guy, Cynthia;Unalp-Arida, Aynur;Colvin, Ryan;Johnson, Richard J.;Diehl, Anna Mae
The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption. Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than age- and BMI-matched controls. Because fructose elicits metabolic perturbations that may be hepatotoxic, we investigated the relationship between fructose consumption and disease severity in NAFLD. We studied 341 adults enrolled in the NASH Clinical Research Network for whom Block food questionnaire data were collected within 3 months of a liver biopsy. Fructose consumption was estimated based on reporting (frequency × amount) of kool-aid, fruit juices, and non-dietary soda intake, expressed as servings per week, and classified into none, occasional (< 7 servings/week), and daily (> = 7 servings/week). The association of fructose intake with metabolic and histologic features of NAFLD was analyzed using multiple linear and logistic regression analyses with and without controlling for other confounding factors. Increased fructose consumption was univariately associated with decreased age (p < 0.0001), male gender (p < 0.0001), hypertriglyceridemia (p < 0.04), low HDL cholesterol (< 0.0001), decreased serum glucose (p < 0.001), increased calorie intake (p < 0.0001) and hyperuricemia (p < 0.0001). After controlling for age, gender, BMI, and total calorie intake, daily fructose consumption was associated with lower steatosis grade and higher fibrosis stage (p < 0.05 for each). In older adults (age > 48 years), daily fructose consumption was associated with increased hepatic inflammation (p < 0.05) and hepatocyte ballooning (p = 0.05). In patients with NAFLD, daily fructose ingestion is associated with reduced hepatic steatosis but increased fibrosis. These results identify a readily modifiable environmental risk factor that may ameliorate disease progression in patients with NAFLD.
登录
查看更多内容
影响因子:
9.8
作者:
Fargion, S;Mattioli, M;Fiorelli, G
通讯作者:
Fiorelli, G
DOI:
10.1073/pnas.78.11.6858
发表时间:
1981-01-01
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES
影响因子:
--
作者:
AMES, BN;CATHCART, R;HOCHSTEIN, P
通讯作者:
HOCHSTEIN, P
影响因子:
5.1
作者:
Caldwell, Stephen H;Chang, Charissa Y;Krugner-Higby, Lisa
通讯作者:
Krugner-Higby, Lisa
影响因子:
2.2
作者:
Chalasani NP;Sanyal AJ;Kowdley KV;Robuck PR;Hoofnagle J;Kleiner DE;Unalp A;Tonascia J;NASH CRN Research Group
通讯作者:
NASH CRN Research Group
影响因子:
4.5
作者:
Basciano, Heather;Federico, Lisa;Adeli, Khosrow
通讯作者:
Adeli, Khosrow